Recent Advances in Flow Cytometry: Platforms, Tools, and Challenges for Data Analysis

Flow Cytometry in Drug Discovery and Development

Volumn , Issue , 2010, Pages 23-54

  Smith, Paul J ^a   Edward, Roy ^b   Errington, Rachel J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Biostatus Ltd   (United Kingdom)

Author keywords

Flow cytometry advances in platforms, tools and challenges for data analysis; Flow cytometry, distinguished track record solutions in screening for antivirals; Platform format advances microflow and new light sources

Indexed keywords

EID: 84871396994     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470910085.ch2     Document Type: Chapter

References (162)

1. Imeri F, Herklotz R, Risch L, Arbetsleitner C, Zerlauth M, Risch GM, Huber AR. Stability of hematological analytes depends on the hematology analyser used: a stability study with Bayer Advia 120, Beckman Coulter LH 750 and Sysmex XE 2100. Clin. Chim. Acta 2008;397(1-2):68-71.
2. Bouvier S, Machon C, Destenay S, Brun S, Arnaud A, Cochery-Nouvellon E, Lissalde- Lavigne G, Gris JC. A new automated haematology analyser: the Excell 2280. Ann. Biol. Clin. (Paris) 2008;66(4):417-426.
3. Sklar LA, Carter MB, Edwards BS. Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening. Curr. Opin. Pharmacol. 2007;7 (5):527-534.
4. Chakraborty C, Hsu CH, Wen ZH, Lin CS, Agoramoorthy G. Zebrafish: a complete animal model for in vivo drug discovery and development. Curr. Drug Metab. 2009;10 (2):116-124.
5. Edwards BS, Kuckuck FW, et al. HTPS flow cytometry: a novel platform for automated high throughput drug discovery and characterization. J. Biomol. Screen. 2001;6(2):83-90.
6. Edwards BS, Oprea T, Prossnitz ER, Sklar LA. Flow cytometry for high-throughput, high-content screening. Curr. Opin. Chem. Biol. 2004;8(4):392-398.
7. Edwards BS, Bologa C, Young SM, Balakin KV, Prossnitz ER, Savchuck NP, Sklar LA, Oprea TI. Integration of virtual screening with high-throughput flowcytometry to identify novel small molecule formylpeptide receptor antagonists. Mol. Pharmacol. 2005;68 (5):1301-1310.
8. Feng Y, Mitchison TJ, Bender A, Young DW, Tallarico JA. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds. Nat. Rev. Drug Discov. 2009;8(7):567-578.
9. Caldwell JS. Cancer cell-based genomic and small molecule screens. Adv. Cancer Res. 2007;96:145-173.
10. Zeisel MB, Barth H, Schuster C, Baumert TF. Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy. Front. Biosci. 2009;14:3274-3285.
11. Ziegler S, Kronenberger B, Albrecht BA, Kaul A, Gamer AL, Klein CD, Hartmann RW. Development and evaluation of a FACS-based medium-throughput assay for HCVentry inhibitors. J. Biomol. Screen. 2009;14(6):620-626.
12. Haney SA. Expanding the repertoire of RNA interference screens for developing new anticancer drug targets. Expert Opin. Ther. Targets 2007;11(11):1429-1441.
13. Vignali DA. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 2000;243(1-2):243-255.
14. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J,Wilson J, Lowe L, Chen R, Shivraj L, Agadir A, et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 2004;110(3):252-266.
15. Woods TA, Graves SW, Nolan JP. Microsphere surface protein determination using flow cytometry. Curr. Protoc. Cytom. 2005; Chapter 13:Unit 13.2.
16. Watson DA, Gaskill DF, Brown LO, Doorn SK, Nolan JP. Spectral measurements of large particles by flow cytometry. Cytometry A 2009;75(5):460-464.
17. Galanzha EI, ShashkovEV, TuchinVV, ZharovVP. In vivo multispectral, multiparameter, photoacoustic lymph flow cytometry with natural cell focusing, label-free detection and multicolor nanoparticle probes. Cytometry A 2008;73(10):884-894.
18. Nolan JP, Yang L. The flow of cytometry into systems biology. Brief. Funct. Genomics Proteomics 2007;6(2):81-90.
19. Khan IA, Husemann P, Campbell L, White NS, White RJ, Smith PJ, Errington RJ. ProgeniDB: a novel cell lineage database for generation associated phenotypic behavior in cell-based assays. Cell Cycle 2007;6(7):868-874.
20. Smith PJ, Khan IA, Errington RJ. Cytomics and drug development. Cytometry A 2007;71(6):349-351.
21. Smith PJ, Khan IA, Errington RJ. Cytomics and cellular informatics: coping with asymmetry and heterogeneity in biological systems. Drug Discov. Today 2009;14 (5-6):271-277.
22. Shapiro HM. Lasers for flow cytometry. Curr. Protoc. Cytom. 2004; Chapter 1:Unit 1.9.
23. Nolan JP, Lauer S, Prossnitz ER, Sklar LA. Flow cytometry: a versatile tool for all phases of drug discovery. Drug Discov. Today 1999;4(4):173-180.
24. Lang P,YeowK, Nichols A, Scheer A. Cellular imaging in drug discovery. Nat. Rev. Drug Discov. 2006;5(4):343-356.
25. Shapiro HM. Scanning laser cytometry. Curr. Protoc. Cytom. 2004; Chapter 2:Unit 2.10.
26. Basiji DA, Ortyn WE, Liang L, Venkatachalam V, Morrissey P. Cellular image analysis and imaging by flow cytometry. Clin. Lab. Med. 2007;27(3):653-670, viii.
27. Kottaridi C, Georgoulakis J, Kassanos D, Pappas A, Spathis A, Margari N, Aninos D, Karakitsos P. Use of flow cytometry as a quality control device for liquid-based cervical cytology specimens. Cytometry B Clin Cytom 2010;78:37-40.
28. Galbraith DW. Simultaneous flow cytometric quantification of plant nuclear DNA contents over the full range of described angiosperm 2C values. Cytometry A 2009;75 (8):692-698.
29. Ortyn WE, Perry DJ, Venkatachalam V, Liang L, Hall BE, Frost K, Basiji DA. Extended depth of field imaging for high speed cell analysis. Cytometry A 2007;71(4):215-231.
30. George TC, Basiji DA, Hall BE, Lynch DH, Ortyn WE, Perry DJ, Seo MJ, Zimmerman CA, Morrissey PJ. Distinguishing modes of cell death using the ImageStream multispectral imaging flow cytometer. Cytometry A 2004;59(2):237-245.
31. George TC, Fanning SL, Fitzgerald-Bocarsly P, Medeiros RB, Highfill S, Shimizu Y, Hall BE, Frost K, Basiji D, Ortyn WE, et al. Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J. Immunol. Methods 2006;311(1-2):117-129.
32. George TC, Morrissey PJ, Cui C, Singh S, Fitzgerald Bocarsly P. Measurement of cytoplasmic to nuclear translocation. Curr. Protoc. Cytom. 2009; Chapter 9:Unit 9.28.
33. Henery S, George T, Hall B, Basiji D, Ortyn W, Morrissey P. Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: a comparison with standard photometric methods. Apoptosis 2008;13(8):1054-1063.
34. McGrath KE, Bushnell TP, Palis J. Multispectral imaging of hematopoietic cells: where flow meets morphology. J. Immunol. Methods 2008;336(2):91-97.
35. Ortyn WE, Hall BE, George TC, Frost K, Basiji DA, Perry DJ, Zimmerman CA, Coder D, Morrissey PJ. Sensitivity measurement and compensation in spectral imaging. Cytometry A 2006;69(8):852-862.
36. WojakowskiW, Tendera M, Kucia M, Zuba-Surma E, Paczkowska E, Ciosek J, Halasa M, Krol M, Kazmierski M, Buszman P, et al. Mobilization of bone marrow-derived Oct-4{thorn} SSEA-4{thorn} very small embryonic-like stem cells in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 2009;53(1):1-9.
37. Elliott GS. Moving pictures: imaging flow cytometry for drug development. Comb. Chem. High Throughput Screen. 2009;12:849-859.
38. Haynes MK, Strouse JJ, Waller A, Leitao A, Curpan RF, Bologa C, Oprea TI, Prossnitz ER, Edwards BS, Sklar LA, et al. Detection of intracellular granularity induction in prostate cancer cell lines by small molecules using the HyperCyt high-throughput flow cytometry system. J. Biomol. Screen. 2009;14(6):596-609.
39. Young SM, Curry MS, Ransom JT, Ballesteros JA, Prossnitz ER, Sklar LA, Edwards BS. High-throughput microfluidic mixing and multiparametric cell sorting for bioactive compound screening. J. Biomol. Screen. 2004;9(2):103-111.
40. Young SM, Bologa C, et al. High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands. J. Biomol. Screen. 2005;10(4): 374-382.
41. Young SM, Bologa C, Prossnitz ER, Oprea TI, Sklar LA, Edwards BS. High-throughput screening with HyperCyt flowcytometry to detect small molecule formylpeptide receptor ligands. J. Biomol. Screen. 2005;10(4):374-382.
42. Naumann U, Wand MP. Automation in high-content flow cytometry screening. Cytometry A 2009;75:789-797.
43. Fulwyler MJ. Electronic separation of biological cells by volume. Science 1965;150 (698):910-911.
44. Bortner CD, Sifre MI, Cidlowski JA. New approaches for determining apoptotic volume decrease in cells. Methods Enzymol. 2007;428:161-181.
45. Krishan A, Cabana R. Flow cytometric analysis of electronic nuclear volume and DNA content in normal mouse tissues. Cell Cycle 2004;3(3):380-383.
46. Thomas RA, Krishan A, Brochu M. High resolution flowcytometric analysis of electronic nuclear volume and DNA content in normal and abnormal human tissue. Methods Cell Sci. 2002;24(1-3):11-18.
47. Postema M, Gilja OH. Ultrasound-directed drug delivery. Curr. Pharm. Biotechnol. 2007;8(6):355-361.
48. Karshafian R, Bevan PD, Williams R, Samac S, Burns PN. Sonoporation by ultrasoundactivated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med. Biol. 2009;35(5):847-860.
49. Dainiak MB, Galaev IY, Kumar A, Plieva FM, Mattiasson B. Chromatography of living cells using supermacroporous hydrogels, cryogels. Adv. Biochem. Eng. Biotechnol. 2007;106:101-127.
50. Radisic M, Iyer RK, Murthy SK. Micro-and nanotechnology in cell separation. Int. J. Nanomed. 2006;1(1):3-14.
51. Pappas D, Wang K. Cellular separations: a review of new challenges in analytical chemistry. Anal. Chim. Acta 2007;601(1):26-35.
52. Dainiak MB, Kumar A, Galaev IY, Mattiasson B. Methods in cell separations. Adv. Biochem. Eng. Biotechnol. 2007;106:1-18.
53. Goddard G, Martin JC, Graves SW, Kaduchak G. Ultrasonic particle-concentration for sheathless focusing of particles for analysis in a flow cytometer. Cytometry A 2006;69 (2):66-74.
54. Goddard GR, Sanders CK, Martin JC, Kaduchak G, Graves SW. Analytical performance of an ultrasonic particle focusing flow cytometer. Anal. Chem. 2007;79(22):8740-8746.
55. Morgan H, Hughes MP, Green NG. Separation of submicron bioparticles by dielectrophoresis. Biophys. J. 1999;77(1):516-525.
56. Li Y, Dalton C, Crabtree HJ, Nilsson G, Kaler KV. Continuous dielectrophoretic cell separation microfluidic device. Lab Chip 2007;7(2):239-248.
57. Cen EG, Dalton C, LiY, Adamia S, Pilarski LM, KalerKV.Acombined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells. J. Microbiol. Methods 2004;58(3):387-401.
58. Kua CH, Lam YC, Rodriguez I,Yang C,Youcef-Toumi K. Dynamic cell fractionation and transportation using moving dielectrophoresis. Anal. Chem. 2007;79(18):6975-6987.
59. Gambari R, Borgatti M, Altomare L, Manaresi N, Medoro G, Romani A, Tartagni M, Guerrieri R. Applications to cancer research of "lab-on-a-chip" devices based on dielectrophoresis (DEP). Technol. Cancer Res. Treat. 2003;2(1):31-40.
60. Coley HM, Labeed FH, Thomas H, Hughes MP. Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity. Biochim. Biophys. Acta 2007;1770(4):601-608.
61. Errington RJ, Ameer-Beg SM, Vojnovic B, Patterson LH, Zloh M, Smith PJ. Advanced microscopy solutions for monitoring the kinetics and dynamics of drug-DNA targeting in living cells. Adv. Drug Deliv. Rev. 2005;57(1):153-167.
62. Huang C, Chen A, Guo M, Yu J. Membrane dielectric responses of bufalin-induced apoptosis in HL-60 cells detected by an electrorotation chip. Biotechnol. Lett. 2007;29 (9):1307-1313.
63. Huang C, Chen A, Wang L, Guo M, Yu J. Electrokinetic measurements of dielectric properties of membrane for apoptotic HL-60 cells on chip-based device. Biomed. Microdevices 2007;9(3):335-343.
64. Gawad S, Cheung K, Seger U, Bertsch A, Renaud P. Dielectric spectroscopy in a micromachined flow cytometer: theoretical and practical considerations. Lab Chip 2004;4(3):241-251.
65. Cheung K, Gawad S, Renaud P. Impedance spectroscopy flow cytometry: on-chip labelfree cell differentiation. Cytometry A 2005;65(2):124-132.
66. Dopp E, Jonas L, Nebe B, Budde A, Knippel E. Dielectric changes in membrane properties and cell interiors of human mesothelial cells in vitro after crocidolite asbestos exposure. Environ. Health Perspect. 2000;108(2):153-158.
67. Huang Y,Wang XB, Gascoyne PR, Becker FF. Membrane dielectric responses of human T-lymphocytes following mitogenic stimulation. Biochim. Biophys. Acta 1999;1417 (1):51-62.
68. Wang X, Becker FF, Gascoyne PR. Membrane dielectric changes indicate induced apoptosis in HL-60 cells more sensitively than surface phosphatidylserine expression or DNA fragmentation. Biochim. Biophys. Acta 2002;1564(2):412-420.
69. Gryczynski I, Gryczynski Z, Lakowicz JR, Yang D, Burke TG. Fluorescence spectral properties of the anticancer drug topotecan by steady-state and frequency domain fluorometry with one-photon and multi-photon excitation. Photochem. Photobiol. 1999;69(4):421-428.
70. Ratanachoo K, Gascoyne PR, Ruchirawat M. Detection of cellular responses to toxicants by dielectrophoresis. Biochim. Biophys. Acta 2002;1564(2):449-458.
71. Vahey MD, Voldman J. An equilibrium method for continuous-flow cell sorting using dielectrophoresis. Anal. Chem. 2008;80(9):3135-3143.
72. Vahey MD, Voldman J. High-throughput cell and particle characterization using isodielectric separation. Anal. Chem. 2009;81(7):2446-2455.
73. Wang K, Solis-Wever X, Aguas C, Liu Y, Li P, Pappas D. Differential mobility cytometry. Anal. Chem. 2009;81(9):3334-3343.
74. Jain KK. The role of nanobiotechnology in drug discovery. Drug Discov. Today 2005;10(21):1435-1442.
75. Jain KK. Personalized clinical laboratory diagnostics. Adv. Clin. Chem. 2009;47:95-119.
76. Jain KK. Role of nanobiotechnology in the development of personalized medicine. Nanomedicine 2009;4(3):249-252.
77. Sohn LL, Saleh OA, Facer GR, Beavis AJ, Allan RS, Notterman DA. Capacitance cytometry: measuring biological cells one by one. Proc. Natl. Acad. Sci. USA 2000;97 (20):10687-10690.
78. Chung TD, Kim HC. Recent advances in miniaturized microfluidic flow cytometry for clinical use. Electrophoresis 2007;28(24):4511-4520.
79. Ateya DA, Erickson JS, Howell PB, Jr., Hilliard LR, Golden JP, Ligler FS. The good, the bad, and the tiny: a review of microflow cytometry. Anal. Bioanal. Chem. 2008;391 (5):1485-1498.
80. Golden JP, Kim JS, Erickson JS, Hilliard LR, Howell PB, Anderson GP, Nasir M, Ligler FS. Multi-wavelength microflow cytometer using groove-generated sheath flow. Lab Chip 2009;9(13):1942-1950.
81. Wlodkowic D, Skommer J, McGuinness D, Faley S, KolchW, Darzynkiewicz Z, Cooper JM. Chip-based dynamic real-time quantification of drug-induced cytotoxicity in human tumor cells. Anal. Chem. 2009;81:6952-6959.
82. Wlodkowic D, Skommer J, Faley S, Darzynkiewicz Z, Cooper JM. Dynamic analysis of apoptosis using cyanineSYTOprobes: from classical to microfluidic cytometry. Exp. Cell Res. 2009;315(10):1706-1714.
83. Kapoor V, Subach FV, Kozlov VG, Grudinin A, Verkhusha VV, Telford WG. New lasers for flow cytometry: filling the gaps. Nat. Methods 2007;4(9):678-679.
84. Telford WG. Small lasers in flow cytometry. Methods Mol. Biol. 2004;263:399-418.
85. Shapiro HM,Perlmutter NG.Violet laser diodes as light sources for cytometry. Cytometry 2001;44(2):133-136.
86. Connally R, Jin D, Piper J. High intensity solid-state UV source for time-gated luminescence microscopy. Cytometry A 2006;69(9):1020-1027.
87. Jin D, Connally R, Piper J. Practical time-gated luminescence flow cytometry. I. Concepts. Cytometry A 2007;71(10):783-796.
88. Jin D, Connally R, Piper J. Practical time-gated luminescence flow cytometry. II. Experimental evaluation using UV LED excitation. Cytometry A 2007;71(10):797-808.
89. Jin D, Piper JA, Leif RC, Yang S, Ferrari BC, Yuan J, Wang G, Vallarino LM, Williams JW. Time-gated flow cytometry: an ultra-high selectivity method to recover ultra-rareevent mu-targets in high-background biosamples. J. Biomed. Opt. 2009;14(2):024023.
90. KapoorV, KarpovV, Linton C, SubachFV,VerkhushaVV, TelfordWG.Solid state yellow and orange lasers for flow cytometry. Cytometry A 2008;73(6):570-577.
91. Telford WG, Subach FV, Verkhusha VV. Supercontinuum white light lasers for flow cytometry. Cytometry A 2009;75(5):450-459.
92. Gourley PL, Gourley MF. Biocavity lasers for biomedicine. Trends Biotechnol. 2000;18(11):443-448.
93. Gourley PL. Semiconductor microlasers: a new approach to cell-structure analysis. Nat. Med. 1996;2(8):942-944.
94. Gourley PL. Nanolasers. Sci. Am. 1998;278(3):56-61.
95. Gourley PL. Brief overview of BioMicroNano technologies. Biotechnol. Prog. 2005;21(1):2-10.
96. Gourley PL, Hendricks JK, McDonald AE, Copeland RG, Barrett KE, Gourley CR, Naviaux RK. Ultrafast nanolaser flow device for detecting cancer in single cells. Biomed. Microdevices 2005;7(4):331-339.
97. Shapiro HM. Excitation and emission spectra of common dyes. Curr. Protoc. Cytom. 2004; Chapter 1:Unit 1.19.
98. Sun L, Zborowski M, Moore LR, Chalmers JJ. Continuous, flow-through immunomagnetic cell sorting in a quadrupole field. Cytometry 1998;33(4):469-475.
99. Lara O, Tong X, Zborowski M, Chalmers JJ. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. Exp. Hematol. 2004;32(10):891-904.
100. Zborowski M, Chalmers JJ. Magnetic cell sorting. Methods Mol. Biol. 2005;295:291-300.
101. Jin X, Zhao Y, Richardson A, Moore L, Williams PS, Zborowski M, Chalmers JJ. Differences in magnetically induced motion of diamagnetic, paramagnetic, and superparamagnetic microparticles detected by cell tracking velocimetry. Analyst 2008;133(12):1767-1775.
102. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307(5709):538-544.
103. Ebenstein Y, Gassman N, Kim S, Antelman J, Kim Y, Ho S, Samuel R, Michalet X,Weiss S. Lighting up individual DNA binding proteins with quantum dots. Nano Lett. 2009;9 (4):1598-1603.
104. Farias PM, Santos BS, Fontes A. Semiconductor fluorescent quantum dots: efficient biolabels in cancer diagnostics. Methods Mol. Biol. 2009;544:407-419.
105. Michalet X, Colyer RA, Antelman J, Siegmund OH, Tremsin A, Vallerga JV, Weiss S. Single-quantum dot imaging with a photon counting camera. Curr. Pharm. Biotechnol. 2009;10(5):543-558.
106. Pinaud F, Michalet X, Bentolila LA, Tsay JM, Doose S, Li JJ, Iyer G,Weiss S. Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials 2006;27(9):1679-1687.
107. Chattopadhyay PK, Price DA, Harper TF, Betts MR, Yu J, Gostick E, Perfetto SP, Goepfert P, Koup RA, De Rosa SC, et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat. Med. 2006;12(8):972-977.
108. Machleidt T, Whitney P, Bi K. Multiplexing of pathway-specific beta-lactamase reporter gene assays by optical coding with Qtracker' nanocrystals. J. Biomol. Screen. 2009;14(7):845-852.
109. Sukhanova A, Susha AS, Bek A, Mayilo S, Rogach AL, Feldmann J, Oleinikov V, Reveil B, Donvito B, Cohen JH, et al. Nanocrystal-encoded fluorescent microbeads for proteomics: antibody profiling and diagnostics of autoimmune diseases. Nano Lett. 2007;7(8):2322-2327.
110. Di Corato R, Piacenza P, Musaro M, Buonsanti R, Cozzoli PD, Zambianchi M, Barbarella G, Cingolani R, Manna L, Pellegrino T. Magnetic-fluorescent colloidal nanobeads: preparation and exploitation in cell separation experiments. Macromol. Biosci. 2009;9:952-958.
111. Nabiev I, Mitchell S, Davies A,Williams Y, Kelleher D, Moore R, Gunko YK, Byrne S, RakovichYP, Donegan JF, et al. Nonfunctionalized nanocrystals can exploit a cell?s active transport machinery delivering them to specific nuclear and cytoplasmic compartments. Nano Lett. 2007;7(11):3452-3461.
112. Vaijayanthimala V, Tzeng YK, Chang HC, Li CL. The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake. Nanotechnology 2009;20 (42):425103.
113. MacFarlane M. Cell death pathways: potential therapeutic targets. Xenobiotica 2009;39(8):616-624.
114. Cai SX, Drewe J, Kemnitzer W. Discovery of 4-aryl-4H-chromenes as potent apoptosis inducers using a cell-and caspase-based Anti-cancer Screening Apoptosis Program (ASAP): SAR studies and the identification of novel vascular disrupting agents. Anticancer Agents Med. Chem. 2009;9(4):437-456.
115. Sauermann M, Hahne F, Schmidt C, Majety M, Rosenfelder H, Bechtel S, Huber W, Poustka A, Arlt D,Wiemann S. High-throughput flow cytometry-based assay to identify apoptosis-inducing proteins. J. Biomol. Screen. 2007;12(4):510-520.
116. Gasparri F, Cappella P, Galvani A. Multiparametric cell cycle analysis by automated microscopy. J. Biomol. Screen. 2006;11(6):586-598.
117. Smith PJ, Blunt N,Wiltshire M, Hoy T, Teesdale-Spittle P, Craven MR,Watson JV, Amos WB, Errington RJ, Patterson LH. Characteristics of a novel deep red/infrared fluorescent cell-permeant DNA probe, DRAQ5, in intact human cells analyzed by flow cytometry, confocal and multiphoton microscopy. Cytometry 2000;40(4):280-291.
118. Edward R. Use of DNA-specific anthraquinone dyes to directly reveal cytoplasmic and nuclear boundaries in live and fixed cells. Mol. Cells 2009;27(4):391-396.
119. Smith PJ, Marquez N,Wiltshire M, Chappell S, Njoh K, Campbell L, Khan IA, Silvestre O, Errington RJ. Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells. Cell Cycle 2007;6(16):2071-2081.
120. Smith PJ, Chin SF, Njoh K, Khan IA, Chappell MJ, Errington RJ. Cell cycle checkpointguarded routes to catenation-induced chromosomal instability. SEB Exp. Biol. Ser. 2008;59:219-242.
121. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009;324(5933):1457-1461.
122. Boyle RG, Travers S. Hypoxia: targeting the tumour. Anticancer Agents Med. Chem. 2006;6(4):281-286.
123. Tredan O, Grantab R, Dumontet C. Can tumor hypoxia be turned into a chemotherapeutic advantage? Bull. Cancer 2008;95(5):528-534.
124. Tredan O, Garbens AB, Lalani AS, Tannock IF. The hypoxia-activated ProDrug AQ4N penetrates deeply in tumor tissues and complements the limited distribution of mitoxantrone. Cancer Res. 2009;69(3):940-947.
125. Patterson LH. Bioreductively activated antitumor N-oxides: the case of AQ4N, a unique approach to hypoxia-activated cancer chemotherapy. Drug Metab. Rev. 2002;34 (3):581-592.
126. Albertella MR, Loadman PM, Jones PH, Phillips RM, Rampling R, Burnet N, Alcock C, Anthoney A, Vjaters E, Dunk CR, et al. Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I study. Clin. Cancer Res. 2008;14(4):1096-1104.
127. O'Rourke M, Ward C, Worthington J, McKenna J, Valentine A, Robson T, Hirst DG, McKeownSr., Evaluation of the antiangiogenic potential of AQ4N. Clin. Cancer Res. 2008;14(5):1502-1509.
128. Smith PJ, Desnoyers R, Blunt N, Giles Y, Patterson LH, Watson JV. Flow cytometric analysis and confocal imaging of anticancer alkylaminoanthraquinones and their N-oxides in intact human cells using 647-nm krypton laser excitation. Cytometry 1997;27 (1):43-53.
129. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of theATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 2003;55(1):3-29.
130. Ivnitski-Steele I, Larson RS, Lovato DM, Khawaja HM,Winter SS, Oprea TI, Sklar LA, Edwards BS. High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters. Assay Drug Dev. Technol. 2008;6(2):263-276.
131. Demel MA, Schwaha R, Kramer O, Ettmayer P, Haaksma EE, Ecker GF. In silico prediction of substrate properties for ABC-multidrug transporters. Expert Opin. Drug Metab. Toxicol. 2008;4(9):1167-1180.
132. Winter SS, LovatoDM,KhawajaHM,Edwards BS, Steele ID,Young SM, Oprea TI, Sklar LA, Larson RS. High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent. J. Biomol. Screen. 2008;13(3):185-193.
133. Reya T, Morrison SJ, Clarke MF,Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414(6859):105-111.
134. Hart LS, El-Deiry WS. Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells. J. Clin. Oncol. 2008;26(17):2901-2910.
135. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008;8(10):755-768.
136. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, et al. Identification of cells initiating human melanomas. Nature 2008;451(7176):345-349.
137. Goodell MA, McKinney-Freeman S, Camargo FD. Isolation and characterization of side population cells. Methods Mol. Biol. 2005;290:343-352.
138. Hirschmann-Jax C, Foster AE, Wulf GG, Goodell MA, Brenner MK. A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy. Cell Cycle 2005;4(2):203-205.
139. Smith PJ, Nakeff A,Watson JV. Flow-cytometric detection of changes in the fluorescence emission spectrum of a vital DNA-specific dye in human tumour cells. Exp. Cell Res. 1985;159(1):37-46.
140. Cabana R, Frolova EG, Kapoor V, Thomas RA, Krishan A, Telford WG. The minimal instrumentation requirements for Hoechst side population analysis: stem cell analysis on low-cost flow cytometry platforms. Stem Cells 2006;24(11):2573-2581.
141. Telford WG,Bradford J, GodfreyW, RobeyRW, Bates SE. Side population analysis using a violet-excited cell-permeable DNA binding dye. Stem Cells 2007;25(4):1029-1036.
142. Hawley TS, Telford WG,Hawley RG. "Rainbow" reporters for multispectral marking and lineage analysis of hematopoietic stem cells. Stem Cells 2001;19(2):118-124.
143. Huuskonen H. New models and molecular markers in evaluation of developmental toxicity. Toxicol. Appl. Pharmacol. 2005;207(2 Suppl.):495-500.
144. Buesen R, Genschow E, Slawik B, Visan A, Spielmann H, Luch A, Seiler A. Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol. Sci. 2009;108 (2):389-400.
145. Kenakin TP. Cellular assays as portals to seven-transmembrane receptor-based drug discovery. Nat. Rev. Drug Discov. 2009;8(8):617-626.
146. Hanson BJ,Wetter J, Bercher MR, Kopp L, Fuerstenau-Sharp M, Vedvik KL, Zielinski T, Doucette C, Whitney PJ, Revankar C. A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment. J. Biomol. Screen. 2009;14(7):798-810.
147. Fang Y, Frutos AG, Verklereen R. Label-free cell-based assays for GPCR screening. Comb. Chem. High Throughput Screen. 2008;11(5):357-369.
148. Roman DL, Talbot JN, Roof RA, Sunahara RK, Traynor JR, Neubig RR. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay. Mol. Pharmacol. 2007;71(1):169-175.
149. Roman DL, Ota S, Neubig RR. Polyplexed flow cytometry protein interaction assay: a novel high-throughput screening paradigm for RGS protein inhibitors. J. Biomol. Screen. 2009;14(6):610-619.
150. Binder C, Lafayette A, Archibeque I, Sun Y, Plewa C, Sinclair A, Emkey R. Optimization and utilization of the SureFire phospho-STAT5 assay for a cell-based screening campaign. Assay Drug Dev. Technol. 2008;6(1):27-37.
151. Chattopadhyay PK, Hogerkorp CM, Roederer M.Achromatic explosion: the development and future of multiparameter flow cytometry. Immunology 2008;125(4):441-449.
152. Hahne F, LeMeur N, Brinkman RR, Ellis B, Haaland P, Sarkar D, Spidlen J, Strain E, Gentleman R. flowCore: a Bioconductor package for high throughput flow cytometry. BMC Bioinformatics 2009;10:106.
153. Le Meur N, Rossini A, Gasparetto M, Smith C, Brinkman RR, Gentleman R. Data quality assessment of ungated flow cytometry data in high throughput experiments. Cytometry A 2007;71(6):393-403.
154. Lo K, Hahne F, Brinkman RR, Gottardo R. flowClust: a Bioconductor package for automated gating of flow cytometry data. BMC Bioinformatics 2009;10:145.
155. Boedigheimer MJ, Ferbas J. Mixture modeling approach to flow cytometry data. Cytometry A 2008;73(5):421-429.
156. Pyne S, Hu X, Wang K, Rossin E, Lin TI, Maier LM, Baecher-Allan C, McLachlan GJ, Tamayo P, Hafler DA, et al. Automated high-dimensional flow cytometric data analysis. Proc. Natl. Acad. Sci. USA 2009;106(21):8519-8524.
157. Editorial. Standardizing data. Nat. Cell Biol. 2008;10(10):1123-1124.
158. Data file standard for flow cytometry. Data File Standards Committee of the Society for Analytical Cytology. Cytometry 1990;11(3):323-332.
159. BrazmaA,Hingamp P,Quackenbush J,SherlockG, Spellman P, StoeckertC,Aach J,Ansorge W, Ball CA, Causton HC, et al. Minimum information about a microarray experiment (MIAME): toward standards for microarray data. Nat. Genet. 2001;29(4):365-371.
160. Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, et al. MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A 2008;73(10):926-930.
161. Qian Y, Tchuvatkina O, Spidlen J, Wilkinson P, Gasparetto M, Jones AR, Manion FJ, Scheuermann RH, Sekaly RP, Brinkman RR. FuGEFlow: data model and markup language for flow cytometry. BMC Bioinformatics 2009;10:184.
162. Jones AR, Miller M, Aebersold R, Apweiler R, Ball CA, Brazma A, Degreef J, Hardy N, Hermjakob H, Hubbard SJ, et al. The Functional Genomics Experiment model (FuGE): an extensible framework for standards in functional genomics. Nat. Biotechnol. 2007;25(10):1127-1133.